However, our study found that women with an HbA1c level of ≥5.7% before 24 weeks of gestation had significantly higher risks of pregnancy and neonatal complications, including the need for insulin to optimize maternal glycemic control and the incidences of macrosomia and shoulder dystocia. This evidence concerns the gene INS and Large for gestational age.